Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.

Borycz J, Zapata A, Quiroz C, Volkow ND, Ferré S.

Neuropsychopharmacology. 2008 Feb;33(3):619-26. Epub 2007 May 9.

2.

Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats.

Pum M, Carey RJ, Huston JP, Müller CP.

Psychopharmacology (Berl). 2007 Aug;193(3):375-90. Epub 2007 Apr 29.

PMID:
17468969
3.

Functional activation by central monoamines of human dopamine D(4) receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes.

Wedemeyer C, Goutman JD, Avale ME, Franchini LF, Rubinstein M, Calvo DJ.

Eur J Pharmacol. 2007 May 21;562(3):165-73. Epub 2007 Feb 8.

PMID:
17350612
4.
5.

Cocaine increases the intracellular calcium concentration in brain independently of its cerebrovascular effects.

Du C, Yu M, Volkow ND, Koretsky AP, Fowler JS, Benveniste H.

J Neurosci. 2006 Nov 8;26(45):11522-31.

6.

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B.

J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1314-22.

PMID:
17023870
7.

Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).

Li D, Sham PC, Owen MJ, He L.

Hum Mol Genet. 2006 Jul 15;15(14):2276-84. Epub 2006 Jun 14.

PMID:
16774975
9.

Stimulant medications: how to minimize their reinforcing effects?

Volkow ND.

Am J Psychiatry. 2006 Mar;163(3):359-61. No abstract available.

PMID:
16513852
10.

[35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.

Czermak C, Lehofer M, Liebmann PM, Traynor J.

Eur J Pharmacol. 2006 Feb 15;531(1-3):20-4. Epub 2006 Jan 19.

PMID:
16423344
11.
12.

The serotonergic system and its role in cocaine addiction.

Filip M, Frankowska M, Zaniewska M, Gołda A, Przegaliński E.

Pharmacol Rep. 2005 Nov-Dec;57(6):685-700. Review.

13.

Mechanisms of neurotransmitter release by amphetamines: a review.

Sulzer D, Sonders MS, Poulsen NW, Galli A.

Prog Neurobiol. 2005 Apr;75(6):406-33. Review.

PMID:
15955613
14.

Molecular genetics of attention-deficit/hyperactivity disorder.

Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P.

Biol Psychiatry. 2005 Jun 1;57(11):1313-23. Epub 2005 Jan 21. Review.

PMID:
15950004
16.

Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.

Gilbert JG, Newman AH, Gardner EL, Ashby CR Jr, Heidbreder CA, Pak AC, Peng XQ, Xi ZX.

Synapse. 2005 Jul;57(1):17-28.

17.
20.

Molecular mechanisms underlying the rewarding effects of cocaine.

Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR.

Ann N Y Acad Sci. 2004 Oct;1025:47-56. Review.

PMID:
15542699

Supplemental Content

Support Center